March 7 (Reuters) - Valeant Pharmaceuticals International Inc (NYSE:)
* Valeant commences cash tender offer for up to $600,000,000 outstanding principal amount of its 6.75 pct senior notes due 2018 Source text for Eikon: ID:nPn82PTv2a Further company coverage: VRX.TO